Andrea Dias
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Andrea Dias has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Guiomar Oliveira
Unidade de Neurodesenvolvimento e Autismo, Serviço do Centro de Desenvolvimento da Criança, Centro de Investigação e Formação Clínica, Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra (CHUC), 3000-602 Coimbra, Portugal
2 shared publications - Joana Verdelho Andrade
Centro Hospitalar Tondela-Viseu E.P.E.
2 shared publications - Alexandra F. Santos
Department of Women and Children's Health (Pediatric Allergy), School of Life Course Sciences, Faculty of Life Sciences and Medicine King's College London London UK
1 shared publication - Ana C Rocha
Faculdade de Medicina da Universidade de Coimbra Coimbra Portugal
1 shared publication - Carla Pinto
Serviço de Cuidados Intensivos Pediátricos. Hospital Pediátrico de Coimbra. Centro Hospitalar e Universitário de Coimbra. Coimbra. Portugal
1 shared publication - Cátia Martins
Co-primeira autora; Serviço de Cuidados Intensivos Pediátricos. Hospital Pediátrico. Unidade Local de Saúde de Coimbra. Coimbra
1 shared publication
Latest Publications
- Open Access
- 2 January 2025
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 38 (1) , 23-36
Infeções Associadas aos Cuidados de Saúde em Idade Pediátrica: 10 Anos de Experiência num Serviço de Cuidados Intensivos
Introdução: As infeções associadas aos cuidados de saúde são uma causa importante de morbimortalidade na população pediátrica, representando um problema crescente nos serviços de cuidados intensivos. Contudo, existem poucos estudos que caracterizam a realidade destas infeções na população pediátrica portuguesa. Este estudo pretendeu avaliar a sua prevalência num serviço de cuidados intensivos pediátrico português, identificando os microrganismos mais frequentes e o respetivo perfil de resistência aos antibióticos.Métodos: Estudo de coorte retrospetivo que incluiu os doentes admitidos num serviço de cuidados intensivos pediátrico entre 1 de janeiro de 2014 e 31 de dezembro de 2023, com diagnóstico de infeções associadas aos cuidados de saúde durante o internamento.Resultados: Identificaram-se 248 casos, correspondendo a uma prevalência de 6,3%, a maioria em lactentes. As infeções mais frequentes forampneumonia (45,2%) e bacteriemia (14,5%), sendo os agentes infeciosos mais comuns os Gram negativos, nomeadamente a Escherichia coli, a Pseudomonasaeruginosa e a Klebsiella pneumoniae. Observou-se um aumento global das resistências antibióticas nos últimos cinco anos (2019 - 2023). A taxa de infeção por bactérias produtoras de ESBL, MRSA e ERC foi, respetivamente, 8,5%, 1,6% e 0,4%, superior nos anos 2019 - 2023. Houve 45 colonizações em 41 doentes (num total de 97 pesquisas realizadas): 40 a ESBL e 5 a ERC (sem colonizações por MRSA). A sépsis ocorreu em 29,8% casos e a mortalidade foi de 11,7% (4,0% devido à IACS). A exposição a tubo endotraqueal e a ventilação invasiva de longa duração associaram-sea maior probabilidade de desenvolver pneumonia (OR = 2,5; IC 95%, 1,1 a 5,9; p = 0,03; e OR = 1,9; IC 95%, 1,1 a 3,4; p = 0,011; respetivamente).Conclusão: É fundamental implementar estratégias eficazes para prevenir e controlar a disseminação das bactérias resistentes, assegurando a eficácia das terapêuticas atuais, a segurança dos doentes e a proteção da saúde pública.
- 2 January 2025
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 38 (1) , 23-36
Open AccessInfeções Associadas aos Cuidados de Saúde em Idade Pediátrica: 10 Anos de Experiência num Serviço de Cuidados Intensivos
Introdução: As infeções associadas aos cuidados de saúde são uma causa importante de morbimortalidade na população pediátrica, representando um problema crescente nos serviços de cuidados intensivos. Contudo, existem poucos estudos que caracterizam a realidade destas infeções na população pediátrica portuguesa. Este estudo pretendeu avaliar a sua prevalência num serviço de cuidados intensivos pediátrico português, identificando os microrganismos mais frequentes e o respetivo perfil de resistência aos antibióticos.Métodos: Estudo de coorte retrospetivo que incluiu os doentes admitidos num serviço de cuidados intensivos pediátrico entre 1 de janeiro de 2014 e 31 de dezembro de 2023, com diagnóstico de infeções associadas aos cuidados de saúde durante o internamento.Resultados: Identificaram-se 248 casos, correspondendo a uma prevalência de 6,3%, a maioria em lactentes. As infeções mais frequentes forampneumonia (45,2%) e bacteriemia (14,5%), sendo os agentes infeciosos mais comuns os Gram negativos, nomeadamente a Escherichia coli, a Pseudomonasaeruginosa e a Klebsiella pneumoniae. Observou-se um aumento global das resistências antibióticas nos últimos cinco anos (2019 - 2023). A taxa de infeção por bactérias produtoras de ESBL, MRSA e ERC foi, respetivamente, 8,5%, 1,6% e 0,4%, superior nos anos 2019 - 2023. Houve 45 colonizações em 41 doentes (num total de 97 pesquisas realizadas): 40 a ESBL e 5 a ERC (sem colonizações por MRSA). A sépsis ocorreu em 29,8% casos e a mortalidade foi de 11,7% (4,0% devido à IACS). A exposição a tubo endotraqueal e a ventilação invasiva de longa duração associaram-sea maior probabilidade de desenvolver pneumonia (OR = 2,5; IC 95%, 1,1 a 5,9; p = 0,03; e OR = 1,9; IC 95%, 1,1 a 3,4; p = 0,011; respetivamente).Conclusão: É fundamental implementar estratégias eficazes para prevenir e controlar a disseminação das bactérias resistentes, assegurando a eficácia das terapêuticas atuais, a segurança dos doentes e a proteção da saúde pública.
- Open Access
- 7 December 2022
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 59 (2) , 328-334
The prognostic value of delta‐lactate in critically ill children
AimThis study aimed to test delta-lactate (Delta L) as a short-term risk stratification method in critically ill children. MethodsAn exploratory study of patients admitted to paediatric intensive care unit (PICU) was conducted. Delta L was calculated as the difference between the maximum lactate concentrations on Days 1 and 2. According to the Delta L cutoff, two groups were considered: low mortality risk (LMR) - Delta L >= 0.05 mmol/L - and high mortality risk (HMR) - Delta L < 0.05 mmol/L. ResultsMortality, both during PICU stay and at 28 days, was statistically associated with elevated serum lactate on D1 and D2, per se. For the 93 cases with elevated lactate on Day 1, and a Delta L cutoff of 0.05 mmol/L, the area under the ROC curve was 0.698 (95% confidence interval, 0.47-0.93). HMR patients scored higher PIM3, were not discharged home until 28 days, counted fewer ventilation-free days and needed renal replacement therapy more often. ConclusionElevated lactate levels at admission, as well as applying the optimal cutoff for Delta L, allowed to predict short-term mortality: if an increase or minimal decrease in lactate maximum levels occurred from D1 to D2, death was almost eight times more probable. In critically ill children, delta-lactate predicts short-term outcome.
- 7 December 2022
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 59 (2) , 328-334
Open AccessThe prognostic value of delta‐lactate in critically ill children
AimThis study aimed to test delta-lactate (Delta L) as a short-term risk stratification method in critically ill children. MethodsAn exploratory study of patients admitted to paediatric intensive care unit (PICU) was conducted. Delta L was calculated as the difference between the maximum lactate concentrations on Days 1 and 2. According to the Delta L cutoff, two groups were considered: low mortality risk (LMR) - Delta L >= 0.05 mmol/L - and high mortality risk (HMR) - Delta L < 0.05 mmol/L. ResultsMortality, both during PICU stay and at 28 days, was statistically associated with elevated serum lactate on D1 and D2, per se. For the 93 cases with elevated lactate on Day 1, and a Delta L cutoff of 0.05 mmol/L, the area under the ROC curve was 0.698 (95% confidence interval, 0.47-0.93). HMR patients scored higher PIM3, were not discharged home until 28 days, counted fewer ventilation-free days and needed renal replacement therapy more often. ConclusionElevated lactate levels at admission, as well as applying the optimal cutoff for Delta L, allowed to predict short-term mortality: if an increase or minimal decrease in lactate maximum levels occurred from D1 to D2, death was almost eight times more probable. In critically ill children, delta-lactate predicts short-term outcome.
- Open Access
- 30 June 2016
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 29 (6) , 373-380
Estratégia Multidimensional na Redução de Infeção Associada a Cateter Venoso Central em Pediatria
Introduction: To determine the central-line associated bloodstream infection rate after implementation of central venous catheter-care practice bundles and guidelines and to compare it with the previous central-line associated bloodstream infection rate. Material and Methods: A prospective, longitudinal, observational descriptive study with an exploratory component was performed in a Pediatric Intensive Care Unit during five months. The universe was composed of every child admitted to Pediatric Intensive Care Unit who inserted a central venous catheter. A comparative study with historical controls was performed to evaluate the result of the intervention (group 1 versus group 2). Results: Seventy five children were included, with a median age of 23 months: 22 (29.3%) newborns; 28 (37.3%) with recent surgery and 32 (43.8%) with underlying illness. A total of 105 central venous catheter were inserted, the majority a single central venous catheter (69.3%), with a mean duration of 6.8 ± 6.7 days. The most common type of central venous catheter was the short-term, non-tunneled central venous catheter (45.7%), while the subclavian and brachial flexure veins were the most frequent insertion sites (both 25.7%). There were no cases of central-line associated bloodstream infection reported during this study. Comparing with historical controls (group 1), both groups were similar regarding age, gender, department of origin and place of central venous catheter insertion. In the current study (group 2), the median length of stay was higher, while the mean duration of central venous catheter (excluding peripherally inserted central line) was similar in both groups. There were no statistical differences regarding central venous catheter caliber and number of lumens. Fewer children admitted to Pediatric Intensive Care Unit had central venous catheter inserted in group 2, with no significant difference between single or multiple central venous catheter. Discussion: After multidimensional strategy implementation there was no reported central-line associated bloodstream infection Conclusions: Efforts must be made to preserve the same degree of multidimensional prevention, in order to confirm the effective reduction of the central-line associated bloodstream infection rate and to allow its maintenance.
- 30 June 2016
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 29 (6) , 373-380
Open AccessEstratégia Multidimensional na Redução de Infeção Associada a Cateter Venoso Central em Pediatria
Introduction: To determine the central-line associated bloodstream infection rate after implementation of central venous catheter-care practice bundles and guidelines and to compare it with the previous central-line associated bloodstream infection rate. Material and Methods: A prospective, longitudinal, observational descriptive study with an exploratory component was performed in a Pediatric Intensive Care Unit during five months. The universe was composed of every child admitted to Pediatric Intensive Care Unit who inserted a central venous catheter. A comparative study with historical controls was performed to evaluate the result of the intervention (group 1 versus group 2). Results: Seventy five children were included, with a median age of 23 months: 22 (29.3%) newborns; 28 (37.3%) with recent surgery and 32 (43.8%) with underlying illness. A total of 105 central venous catheter were inserted, the majority a single central venous catheter (69.3%), with a mean duration of 6.8 ± 6.7 days. The most common type of central venous catheter was the short-term, non-tunneled central venous catheter (45.7%), while the subclavian and brachial flexure veins were the most frequent insertion sites (both 25.7%). There were no cases of central-line associated bloodstream infection reported during this study. Comparing with historical controls (group 1), both groups were similar regarding age, gender, department of origin and place of central venous catheter insertion. In the current study (group 2), the median length of stay was higher, while the mean duration of central venous catheter (excluding peripherally inserted central line) was similar in both groups. There were no statistical differences regarding central venous catheter caliber and number of lumens. Fewer children admitted to Pediatric Intensive Care Unit had central venous catheter inserted in group 2, with no significant difference between single or multiple central venous catheter. Discussion: After multidimensional strategy implementation there was no reported central-line associated bloodstream infection Conclusions: Efforts must be made to preserve the same degree of multidimensional prevention, in order to confirm the effective reduction of the central-line associated bloodstream infection rate and to allow its maintenance.
- 1 January 2010
- Published by Codon Publications in Allergologia et Immunopathologia
- Vol. 38 (1) , 8-12
Persistence of cow's milk allergy beyond two years of age
Cow's milk allergy (CMA) epidemiology seems to be changing over time, with an increase in prevalence and persistence. Our aim was to characterise a population of children with CMA beyond two years of age, followed up in a Paediatric Allergy Clinic at the tertiary care level. Retrospective study of children with persistent CMA diagnosed from January 1997 to June 2006. Medical records were analysed regarding: clinical presentation, follow-up, treatment and acquisition of tolerance. Data analysis was performed using Excel 2007 for Windows. Seventy-nine children were included, with mean age at first symptoms of 3 months. The symptoms were immediate in 93%, with cutaneous (87.3%), gastrointestinal (55.7%) and respiratory (25.3%) manifestations. During the follow-up period, 30% developed atopic eczema, 52% asthma and 35% rhinoconjunctivitis. A family history of atopy was identified in 53%. The majority presented increased serum total IgE (376+/-723 KU/l) and positive skin prick test (SPT) to cow's milk (CM) (79%). SPT to goat's milk was positive in 2/3 of cases. Fifty-five percent had at least one accidental exposure to CM (severe reactions in 6%). During CM elimination diet, 35% were initially given an extensively hydrolysed formula, 17% a soy formula, and 48% both. By the age of 10 years, 44% of children persisted with CMA. Our population of CM allergic children presented immediate symptoms with cutaneous expression in the majority. Severe reactions were common on accidental exposure. By the age of 10 years, 44% maintained CMA, highlighting the importance of a multidisciplinary follow-up.
- 1 January 2010
- Published by Codon Publications in Allergologia et Immunopathologia
- Vol. 38 (1) , 8-12
Persistence of cow's milk allergy beyond two years of age
Cow's milk allergy (CMA) epidemiology seems to be changing over time, with an increase in prevalence and persistence. Our aim was to characterise a population of children with CMA beyond two years of age, followed up in a Paediatric Allergy Clinic at the tertiary care level. Retrospective study of children with persistent CMA diagnosed from January 1997 to June 2006. Medical records were analysed regarding: clinical presentation, follow-up, treatment and acquisition of tolerance. Data analysis was performed using Excel 2007 for Windows. Seventy-nine children were included, with mean age at first symptoms of 3 months. The symptoms were immediate in 93%, with cutaneous (87.3%), gastrointestinal (55.7%) and respiratory (25.3%) manifestations. During the follow-up period, 30% developed atopic eczema, 52% asthma and 35% rhinoconjunctivitis. A family history of atopy was identified in 53%. The majority presented increased serum total IgE (376+/-723 KU/l) and positive skin prick test (SPT) to cow's milk (CM) (79%). SPT to goat's milk was positive in 2/3 of cases. Fifty-five percent had at least one accidental exposure to CM (severe reactions in 6%). During CM elimination diet, 35% were initially given an extensively hydrolysed formula, 17% a soy formula, and 48% both. By the age of 10 years, 44% of children persisted with CMA. Our population of CM allergic children presented immediate symptoms with cutaneous expression in the majority. Severe reactions were common on accidental exposure. By the age of 10 years, 44% maintained CMA, highlighting the importance of a multidisciplinary follow-up.